Dave Muoio

November 14, 2018
De Novo clearance for urinary incontinence wearable. The FDA has granted De Novo clearance to Atlantic Therapeutics’ Innovo therapy device, an externally worn electrical muscle stimulator for the treatment of stress urinary incontinence. The wearable is intended for adult women as a front-line or second-line therapy, and in a multi-center randomized controlled trial recorded an 87 percent rate of...
November 14, 2018
Starting this month, UnitedHealthcare members enrolled in the insurer’s incentive-based “Motion” program are able track their daily activity using their personal Apple Watch, or one purchased and earned through the program. This comes roughly half a year after UnitedHealthcare first announced the availability back in March, and a few months after the July rollout planned at the time. Through the...
November 14, 2018
Virtual care provider Teladoc Health recently highlighted two major collaborations with academic institutions focused on the advancement of telehealth delivery and practices. The first of these, conducted with Pennsylvania-based Jefferson Health, launched what the pair consider to be “the industry’s first academic fellowship program in the field of telehealth.” The program, which launched during...
November 13, 2018
Switzerland-based MindMaze announced yesterday its acquisition of fellow neuro-rehabilitation tech company Neuro Motor Innovations Corporation (NMI) for an undisclosed sum. According to the announcement, MindMaze will acquire a perpetual license to NMI’s rehabilitation technology and pick up NMI cofounder Dr. John Krakauer as its now chief medical and chief scientific advisor. Krakauer and...
November 13, 2018
The National Institutes of Health’s support of digital health technologies and research continues with its latest grant, a $13.4 million award to Pennsylvania State University. According to an article from Penn State’s news group, the money will support an investigation that uses mobile devices and applications to explore the development of late-in-life neurological conditions. In addition, the...
November 13, 2018
Knowtions Research, the maker of an artificial intelligence insights platform for heath insurers, has raised $5 million in Series A funding. The round was led by Information Venture Partners, with additional support from Alibaba Entrepreneurs Fund. The company said in its announcement that the new financing will be put toward scaling the deployment of its Lydia AI platform and doubling its team...
November 13, 2018
GreatCall, a tech company for aging individuals that was recently acquired by Best Buy, has partnered with Lyft to launch GreatCall Rides, a service that allows seniors to book rides without the use of a smartphone app. Instead, seniors with Jitterbug phones press a single button to be connected to an operator that will coordinate the ride. The service was piloted in five markets, and is now...
November 12, 2018
Driver, the pricey mobile app designed to link cancer patients to appropriate treatment or relevant clinical trials, appears to have bitten off a bit more than it could chew. This morning STAT reported that the service, which only launched in September, ran out of funds and released its entire 85-employee staff in mid-October, effectively shuttering the business. Driver CEO and cofounder Dr....
November 12, 2018
New data from an international study of AliveCor’s smartphone app and accompanying two-wire ECG found the mobile tool to be on par with a standard 12-lead ECG among patients presenting with ST-segment elevation myocardial infarction (STEMI). In the study — which was conducted in conjunction with AliveCor and presented this weekend at the American Heart Association’s 2018 Scientific Session in...
November 8, 2018
Clinical diagnostic and workflow software maker MaxQ AI has received FDA 510(k) marketing clearance for Accipio Ix, an artificial intelligence workflow tool designed to help clinicians prioritize adults patients likely presenting with acute intracranial hemorrhage. The company received notification from the FDA of its decision in late October. Results generated by the algorithm-based software are...